Malcolm Salter

Director, C4 Therapeutics (United States).

Companies

C4 Therapeutics (United States)Board member Oct 1, 2020 to Jun 21, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

C4 Therapeutics (United States) CCCC11,380 shares²$32.8K at $2.88Jan 4, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 4, 2022Granted 428 shares at $31.58 of C4 Therapeutics (United States)²
Dec 17, 2021Sold 755 shares at $30.25 of C4 Therapeutics (United States)³
Nov 19, 2021Sold 755 shares at $40.11 of C4 Therapeutics (United States)⁴
Oct 15, 2021Sold 755 shares at $44.94 of C4 Therapeutics (United States)⁵
Oct 4, 2021Granted 300 shares at $44.99 of C4 Therapeutics (United States)⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARC4 Therapeutics (United States), Board member
2
SEC EDGARC4 Therapeutics (United States) shares after the filing of Jan 4, 2022
3
SEC EDGARForm 4 filed Dec 17, 2021
4
SEC EDGARForm 4 filed Nov 19, 2021
5
SEC EDGARForm 4 filed Oct 15, 2021
6
SEC EDGARForm 4 filed Oct 5, 2021